Latest Earnings Released (Q4 FY22): Reported quarterly statutory revenue of ₹16.00 Cr with net profit of ₹0.50 Cr (EPS: ₹0.59).
Exchange Disclosure (2026-09-09): Announcement under Regulation 30 (LODR)-Newspaper Publication —
Official listing profile for Arihant Foundations & Housing Limited under Diversified.
Official listing profile for Arihant Foundations & Housing Limited under Diversified.
Commercial & Industrial
- YoY revenue contraction (-77.4%)
- Net profit decline observed YoY (-60.5%)
- Subdued Return on Equity below 6% (1.7%)
- Operating loss / negative operating margin
- Tight interest coverage safety buffer (-60.7x)
| Annual Metric (₹ Cr) | FY20 Dec 2020 | FY21 Mar 2024 | FY22 Jun 2021 |
|---|---|---|---|
| Sales / Revenue from Operations | ₹0.97 | ₹31 | ₹6.94 |
| Operating Expenditure | ₹2.06 | ₹0.40 | ₹0.23 |
| Operating Profit (EBITDA) | ₹-1.09 | ₹-14 | ₹-3.64 |
| Operating Profit Margin (OPM %) | -112.37% | -45.33% | -52.45% |
| Other Income | ₹1.80 | ₹0.16 | ₹0.07 |
| Finance Costs / Interest | ₹0.49 | ₹0.06 | ₹0.06 |
| Depreciation & Amortization | ₹0.08 | ₹0 | ₹0 |
| Profit Before Tax (PBT) | ₹0.14 | ₹0.59 | ₹0.20 |
| Tax Expense | ₹0.02 | ₹0 | ₹0 |
| Net Profit (PAT) | ₹0.12 | ₹0.38 | ₹0.15 |
| Net Profit Margin (NPM %) | 12.37% | 1.24% | 2.16% |
| Basic / Diluted EPS (₹) | ₹0.14 | ₹0.44 | ₹0.18 |
| Cash from Operations (CFO) | N/A | ₹-12 | ₹-27 |
| Free Cash Flow (FCF) | N/A | ₹-12 | ₹-27 |
| Quarterly Metric (₹ Cr) | Q2 FY21 Sep 2020 | Q3 FY21 Dec 2020 | Q4 FY21 Mar 2021 | Q1 FY22 Jun 2021 | Q2 FY22 Sep 2021 | Q4 FY22 Mar 2022 |
|---|---|---|---|---|---|---|
| Sales / Revenue | ₹0.92 | ₹0.97 | ₹29 | ₹6.94 | ₹16 | ₹16 |
| Operating Profit (EBITDA) | ₹-1.59 | ₹-1.66 | ₹-11 | ₹-3.64 | ₹-2.49 | ₹-0.74 |
| OPM % | -172.83% | -171.13% | -37.02% | -52.45% | -15.56% | -4.63% |
| Profit Before Tax (PBT) | ₹0.20 | ₹0.14 | ₹0.25 | ₹0.20 | ₹0.64 | ₹0.64 |
| Net Profit (PAT) | ₹0.17 | ₹0.12 | ₹0.09 | ₹0.15 | ₹0.50 | ₹0.50 |
| NPM % | 18.48% | 12.37% | 0.31% | 2.16% | 3.13% | 3.13% |
| Basic / Diluted EPS (₹) | ₹0.20 | ₹0.14 | ₹0.10 | ₹0.18 | ₹0.59 | ₹0.59 |
| Balance Sheet Item (₹ Cr) | FY20 | FY21 | FY22 |
|---|---|---|---|
| Equity Share Capital | ₹8.60 | ₹8.60 | ₹8.60 |
| Reserves & Surplus | N/A | ₹0 | N/A |
| Net Worth (Shareholders' Funds) | ₹8.60 | ₹8.60 | ₹8.60 |
| Total Borrowings & Debt | N/A | N/A | N/A |
| Total Balance Sheet Assets | N/A | N/A | N/A |
| Cash Flow Item (₹ Cr) | FY20 | FY21 | FY22 |
|---|---|---|---|
| Cash Flow from Operating Activities (CFO) | N/A | ₹-12 | ₹-27 |
| Cash Flow from Investing Activities (CFI) | N/A | ₹2.20 | ₹10 |
| Cash Flow from Financing Activities (CFF) | N/A | ₹-0.72 | ₹16 |
| Free Cash Flow / Net Cash Flow | N/A | ₹-12 | ₹-27 |
| Financial Ratio / Efficiency Metric | FY20 | FY21 | FY22 |
|---|---|---|---|
| Operating Profit Margin (OPM) | -112.37% | -45.33% | -52.45% |
| Net Profit Margin (NPM) | 12.37% | 1.24% | 2.16% |
| Return on Equity (ROE) | 1.40% | 4.42% | 1.74% |
| Return on Capital Employed (ROCE) | 7.33% | 7.56% | 3.02% |
| Debt to Equity Ratio | N/A | N/A | N/A |
| Interest Coverage Ratio | -2.2x | -232.0x | -60.7x |
| CFO to Net Profit Conversion | N/A | -32.76x | -181.67x |
| Type | Ex-Date | Record Date | Amount / Ratio | Description |
|---|---|---|---|---|
| DIVIDEND | 2026-09-15 | 2026-09-15 | ₹2.00 | Final Dividend - Rs. - 2.0000 |
| DIVIDEND | 2026-09-15 | 2026-09-15 | ₹7.00 | Final Dividend - Rs. - 7.0000 |
| DIVIDEND | 2026-09-15 | 2026-09-15 | ₹0.50 | Final Dividend - Rs. - 0.5000 |
| DIVIDEND | 2026-09-15 | 2026-09-15 | ₹5.00 | Final Dividend - Rs. - 5.0000 |
| DIVIDEND | 2026-09-15 | 2026-09-15 | ₹0.55 | Final Dividend - Rs. - 0.5500 |
| DIVIDEND | 2026-09-15 | 2026-09-15 | ₹25.00 | Final Dividend - Rs. - 25.0000 |
| DIVIDEND | 2026-09-15 | 2026-09-15 | ₹3.00 | Final Dividend - Rs. - 3.0000 |
| CORPORATE_ACTION | 2026-09-15 | 2026-09-15 | N/A | Right Issue of Equity Shares |
| DIVIDEND | 2026-09-15 | 2026-09-15 | ₹1.00 | Final Dividend - Rs. - 1.0000 |
| DIVIDEND | 2026-09-15 | 2026-09-15 | ₹0.30 | Final Dividend - Rs. - 0.3000 |
| CORPORATE_ACTION | 2021-09-21 | N/A | N/A | Annual General Meeting |
| CORPORATE_ACTION | 2020-12-15 | N/A | N/A | Annual General Meeting |
| CORPORATE_ACTION | 2019-09-20 | N/A | N/A | Annual General Meeting |
| CORPORATE_ACTION | 2018-09-21 | N/A | N/A | Annual General Meeting |
| CORPORATE_ACTION | 2017-09-14 | N/A | N/A | Annual General Meeting |
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company, at its meeting held today i.e., 14th August 2026, has, inter alia, approved the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter ended June 30, 2026, along with the Limited Review Report issued by the Statutory Auditors. A copy of the same is enclosed herewith. Further, in terms of Regulation 30 read with Schedule III of the SEBI (LODR) Regulations, 2015, we are also enclosing herewith a copy of the Press Release on the said financial results for your information and records. The Board Meeting commenced at 07:30 A.M. and concluded at 08:15 A.M. You are requested to kindly take the above information on record.
Final Dividend - Rs. - 2.0000
Final Dividend - Rs. - 7.0000
Final Dividend - Rs. - 0.5000
Final Dividend - Rs. - 5.0000
Final Dividend - Rs. - 0.5500
Final Dividend - Rs. - 25.0000
Final Dividend - Rs. - 3.0000
Right Issue of Equity Shares
Final Dividend - Rs. - 1.0000
Final Dividend - Rs. - 0.3000
Final Dividend - Rs. - 2.0000
Final Dividend - Rs. - 7.0000
Every financial metric, balance-sheet balance, and shareholding breakdown displayed on this dossier is grounded in primary statutory filings submitted to Indian stock exchanges (SEBI LODR Regulations 31, 33, and 47). No data is manufactured, estimated, or interpolated.
| Data Domain | Reporting Period | Statutory Source | Ingestion Date | Status | Provenance Hash |
|---|---|---|---|---|---|
| financials_quarterly | Q2 FY22 | NSE_OFFICIAL_API | 03 Nov 2026, 12:05 | VERIFIED | 7b89e1a7402b... |
| financials_quarterly | Q2 FY22 | NSE_OFFICIAL_API | 31 Oct 2026, 08:46 | VERIFIED | 7b89e1a7402b... |
| financials_quarterly | Q2 FY22 | NSE_OFFICIAL_API | 28 Oct 2026, 07:45 | VERIFIED | 7b89e1a7402b... |
| financials_quarterly | Q2 FY22 | NSE_OFFICIAL_API | 25 Oct 2026, 14:45 | VERIFIED | 7b89e1a7402b... |
| financials_quarterly | Q2 FY22 | NSE_OFFICIAL_API | 21 Oct 2026, 19:45 | VERIFIED | 7b89e1a7402b... |
| financials_quarterly | Q2 FY22 | NSE_OFFICIAL_API | 17 Oct 2026, 08:26 | VERIFIED | 7b89e1a7402b... |
| financials_quarterly | Q2 FY22 | NSE_OFFICIAL_API | 12 Oct 2026, 18:42 | VERIFIED | 7b89e1a7402b... |
DATA SOURCES, STATUTORY DISCLOSURES & METHODOLOGY
All corporate identifiers, listed equity data, shareholding patterns, and financial statements are extracted from official regulatory authorities: National Stock Exchange of India (NSE), BSE Limited, and Ministry of Corporate Affairs (MCA) via audited XBRL Ind-AS submissions under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Regulations 31, 33, and 47). Data is ingested and archived on official end-of-day (EOD) schedules with immutable provenance tracking.
Zero-Fabrication Policy: SRK Money Talk strictly enforces authentic data integrity. No financial values, debt levels, cash flows, or quarterly earnings are ever mathematically synthesized, interpolated, or fabricated. When statutory disclosures have not yet been filed or ingested, fields are strictly labeled as N/A or NOT_YET_AVAILABLE.
Statutory Disclaimer: The SRK Fundamental Health Score is a quantitative diagnostic algorithm based exclusively on historical audited filings and does not constitute an investment recommendation or financial advisory. Always consult a SEBI-registered investment adviser before making capital allocation decisions.